Medicare Enrolled

Dr. Priya Nair, M.D.

Rheumatology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
712 N WASHINGTON AVE, Dallas, TX 75246
2148236503
In practice since 2006 (19 years)
NPI: 1144245275 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nair? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nair

Dr. Priya Nair is a rheumatology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nair performed 12,228 Medicare services across 1,825 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nair received a total of $52,943 from 41 pharmaceutical and/or device companies across 1005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nair is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 37% volume in TX $52,943 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,228
Medicare services
Top 37% in TX for rheumatology
1,825
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~644 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
4,340 $26 $35
Denosumab injection (Prolia/Xgeva) 3,660 $18 $23
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
782 $88 $130
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
506 $10 $12
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
491 $4 $5
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
467 $8 $8
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
426 $5 $6
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
315 $3 $3
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
234 $55 $76
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
185 $29 $30
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
104 $49 $66
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
103 $97 $142
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
99 $21 $29
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
94 $61 $92
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
59 $2 $4
Complement and antigen measurement
A laboratory test to measure levels of complement proteins and antigens in the blood.
38 $11 $14
Complement function test
A blood test that measures the activity of complement proteins, which are part of the immune system.
38 $11 $15
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $43 $57
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
36 $107 $170
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
33 $48 $71
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
30 $12 $22
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
25 $3 $4
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
23 $36 $55
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
19 $4 $5
Injection, methylprednisolone acetate, 40 mg 16 $5 $7
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
16 $8 $14
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
15 $14 $23
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
13 $6 $9
New patient office visit, complex (60-74 min) 12 $153 $222
Trabecular bone score calculation
This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk.
11 $32 $41
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.2% high complexity
33.6% medium
29.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$52,943
Total received (2018-2024)
Avg $7,563/year across 7 years
Top 10% in TX for rheumatology
41
Companies
1,005
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,119 (72.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,825 (28.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,929
2023
$2,655
2022
$2,434
2021
$2,739
2020
$9,992
2019
$29,055
2018
$4,140

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie, Inc.
$29,158
AbbVie Inc.
$9,933
ABBVIE INC.
$2,602
Amgen Inc.
$2,185
Novartis Pharmaceuticals Corporation
$1,797
Janssen Biotech, Inc.
$1,403
PFIZER INC.
$839
GlaxoSmithKline, LLC.
$770
Lilly USA, LLC
$673
Horizon Therapeutics plc
$470
GENZYME CORPORATION
$369
AstraZeneca Pharmaceuticals LP
$341
UCB, Inc.
$307
Genentech USA, Inc.
$277
Celgene Corporation
$219
E.R. Squibb & Sons, L.L.C.
$200
ANI Pharmaceuticals, Inc.
$190
Radius Health, Inc.
$159
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
Mallinckrodt LLC
$142
Mallinckrodt Hospital Products Inc.
$70
Aurinia Pharma U.S., Inc.
$70
Antares Pharma, Inc.
$69
MEDEXUS PHARMA, INC.
$62
DePuy Synthes Sales Inc.
$53
Organon LLC
$51
Mallinckrodt Enterprises LLC
$51
West-Ward Pharmaceuticals
$42
TerSera Therapeutics LLC
$40
SANOFI-AVENTIS U.S. LLC
$40
Fresenius Kabi USA, LLC
$40
Exeltis, USA Inc.
$28
MEDAC PHARMA, INC.
$23
SCILEX PHARMACEUTICALS INC.
$23
Regeneron Healthcare Solutions, Inc.
$21
Sobi, Inc
$17
Ferring Pharmaceuticals Inc.
$15
Kiniksa Pharmaceuticals International, plc
$13
Horizon Pharma plc
$13
Merck Sharp & Dohme Corporation
$12
Mission Pharmacal Company
$12
Top 3 companies account for 78.8% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AMJEVITA · AVSOLA · Actemra · Aquoral · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · DUPIXENT · EUFLEXXA · EVENITY · Enbrel · HUMIRA · Humira · IDACIO · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for rheumatology in TX.

Equivalent to $433 per 100 Medicare services performed
Looking for a rheumatology specialist in Dallas?
Compare rheumatologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
95
Per 100K population
3.6
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nair is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 10% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nair experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Nair performed 4,340 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nair receive payments from pharmaceutical companies?
Yes. Dr. Nair received a total of $52,943 from 41 companies across 1,005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nair's costs compare to other rheumatologists in Dallas?
Dr. Nair's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →